Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ENVARSUS XR
- Pharmacokinetics, Effectiveness and Tolerability of Prolonged-release Tacrolimus After Paediatric Kidney Transplantation
- Conversion of Maintenance Prograf to Envarsus in Liver Transplant Recipients
- Extended-Release Tacrolimus Following Liver Transplantation
- Tacrolimus Versus Mycophenolate for Autoimmune Hepatitis Patients With Incomplete Response on First Line Therapy
- Tacrolimus Associated Tremors in Liver Transplantation: Immediate-Release Versus Extended-Release Formulations
- ENvarsus for Impaired Glucose Tolerance Post REnal transplAnT
- Renal Tubular Injury and Transplant Outcomes in Cardiac Recipients Converting From IR Tacrolimus to XR Tacrolimus
- Cognitive Outcomes in Stable Renal Transplant Patients Switched fromTacrolimus to Envarsus XR™
- Bioavailability and Practicability of Envarsus Versus Advagraf in Liver Transplant Recipients
- Efficacy of Envarsus XR and Digital Health Technology in Reducing Tacrolimus Fluctuation and Frequency of Dose Changes
- Evaluation of Anti-rejection Drug, Tacrolimus, in African-Americans With Kidney Transplant
- PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus
- P-glypoprotein Inhibition Effect on the Pharmacokinetics of Two Tacrolimus Formulations: Prolonged and Extended-release
- Early Use of Long-acting Tacrolimus in Lung Transplant Recipients
- Envarsus XR in Lung Transplant
- Comparison of Tacrolimus Extended-Release (Envarsus XR) to Tacrolimus Immediate-Release in HLA Sensitized Kidney Transplant Recipients
- Immunosuppressant Medication Dosed Daily After Kidney Transplant
- Envarsus XR Compared to Immediate Release Tacrolimus
- Envarsus in Delayed Graft Function (E-DGF)
- Pulse Wave Velocity, Tacrolimus Time in Therapeutic Range and CV in African American Kidney Transplants
- Veloxis de Novo Kidney Transplant ECSWD
- Envarsus XL Immunosuppression Following Liver Transplantation
- Envarsus Neurotoxicity Burden in Liver Transplant Patients
- RCT Comparing Immunosuppressive Regimens in Elderly Renal Transplant Recipients
- CIRTEN-Simultaneous Pancreas-Kidney Transplant Recipients
- Conversion to Envarsus Post Kidney Transplant Protects Against BK Infection
- Evaluation Dose Adjustments in Kidney Transplant Patients on Immediate Release and Extended Release Tacrolimus
- Comparison of Safety and Efficacy of Two Variants of Prolonged - Released Tacrolimus (Advagraf vs. Envarsus ) in Patients After Liver Transplantation : Single Center Randomised Control Trial
- Once Daily Immunosuppression Regimen
- Envarsus on the Effect of Total Tacrolimus Dose/Trough Level Ratio on Renal Function (eGFR) in Kidney Transplantation
- A Pilot Study to Evaluate Impact on Neurological Side Effects (Cognition, Memory, and Tremor) in Elderly (Age>65) Patients
- Prospective Pilot Feasibility Study Comparing Envarsus Once-a-day to Tacrolimus Twice-a-day Immunosuppressive Regimen on Drug Bioavailability in Hispanic First Time Kidney Transplant Recipients
- Comparison of the Cognitive and Motor Effects of Treatment Between an Immediate- and Extended-release Tacrolimus (Envarsus® XR) Based Immunosuppression Regimen in Kidney Transplant Recipients
- Assessment of Cognitive Function Before and After Conversion From Immediate Release Tacrolimus to Envarsus XR.
- Pilot Study of Treatment for Subclinical AMR (Antibody-mediated Rejection) in Kidney Transplant Recipients
- Phase II Study Evaluating the Efficacy of Tacrolimus Extended Release Tablets to Twice Daily Tacrolimus Dosing Regimen
- Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
- Extended Release Tacrolimus vs. Twice-Daily Tacrolimus
- CNS Study of Patients Switching From Tacrolimus to Envarsus
- Envarsus XR® in Adolescent Renal Transplant Recipients
- AGe-adapted Benefits of Envarsus Versus Twice-daily Tacrolimus ImmunosuppressioN druGs After Kidney Transplantation
- Envarsus® Once Daily With Everolimus in Elderly Kidney Transplant Recipients: Pharmacokinetic and Clinical Study
- Envarsus XR in African American Renal Transplant Recipients
- Once-daily Regimen With Envarsus® to Optimize Immunosuppression Management and Outcomes in Kidney Transplant Recipients
- PK Assessment of Tacrolimus Exposure Before and After a Switch From Twice Daily Immediate-release (Prograf®) to Once-daily Prolonged Release Tacrolimus (Envarsus®)
- Pharmacokinetic Study of ENVARSUS in Adult De-novo Kidney Transplant Patients
- Multicentre, Open Label, Randomized, Two-arm, Parallel-group Study to Assess Efficacy and Safety of ENVARSUS® Compared With Tacrolimus Used as Per Current Clinical Practice in the Initial Maintenance Setting in de Novo Kidney Transplant Patients
- Expanded Access Study for Renal Transplant Patients With Envarsus XR ™
- Pharmacokinetic Comparison Of All FK-506 Formulations
Clinical trials list
click for details